Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

NOI to Sole Source AMICUS Apheresis Reagents & Consumables

Active
HT941026N0107 Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Health Agency Contracting Activity intends to award a firm-fixed-price sole source contract to Fenwal, Inc. for the drop shipment of FDA Fenwal Amicus Apheresis Reagents. This procurement is designed to support the operational requirements of the Naval Hospital Okinawa in Japan, specifically for the collection, treatment, and sustainment of blood platelet products. These reagents and processing sets are critical for pathogen reduction processes mandated by the FDA to ensure patient safety and mission readiness. The contract covers a delivery period from October 1, 2026, through September 30, 2027, with delivery routed through the DLA Troop Support XDock West Project in Ontario, California. Classified under NAICS code 325413, the acquisition is being executed as a sole source because Fenwal, Inc. is identified as the only manufacturer capable of meeting the government's requirements. Interested parties wishing to challenge this intent must submit a detailed capability statement by August 28, 2026.

General Info

Sole source contract to Fenwal, Inc. for apheresis reagents supporting Naval Hospital Okinawa.

Agency

Department Of Defense → Defense Health Agency Hcd WestView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

CA, USA

Set-Aside

NONE

Documents

(1)

HT941026N0107+NOI+NHO+AMICUS+Cell+Separator+Sys+Consumables.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSources Sought
Posted

Sources Sought

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Hcd West
Contacts2 people available
OfficeCAMP PENDLETON, CA, 92055, USA
Organization / Agency
Department Of Defense → Defense Health Agency Hcd West
View Agency Profile
Office AddressCAMP PENDLETON, CA, 92055, USA
Contacts
Mariangela Monsalve

Full Description

Show more

Notice of Intent to Sole Source HT941026N0107


THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES.


The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – West (HCD-W), intends to award a firm-fixed-price purchase order for Drop Shipment of FDA Fenwal Amicus Apheresis Reagents (Manufacturer: Fenwal, Inc.). This procurement supports the operational requirements of Naval Hospital Okinawa, Japan, and is conducted in accordance with Federal Acquisition Regulation (FAR) 12.102(a), this acquisition of commercial products and services is being executed as a sole source, as the Contracting Officer does not have a reasonable expectation that two or more offers will be received.


FENWAL, INC., 3 CORPORATE DR STE 300, LAKE ZURICH, IL 60047-8930, United States


UEI: E9UHXHZCGJV5


CAGE: 4Q7Q2


The North American Industry Classification System (NAICS) code for this requirement is 325413, In-Vitro Diagnostic Substance Manufacturing, which has a business size standard of 1,250 employees. The product service code (PSC) is 6550, In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets.


The objective of this sole source award is to procure Amicus Apheresis reagents for the cell separator for Naval Hospital Okinawa, located at Bldg 960, Tarawa Road, Camp Foster, Okinawa, Japan.


The requested Intecept platelet small volume processing set and platelet dual storage containers are used in the Intercept pathogen reducing equipment. These items are vital in the collection, treatment and sustainment of adequate inventory of blood platelets products for routine and emergent patient care and mission requirement. Pathogen reduction of donated blood platelet products reduces the transmission of viruses and infections upon transfusion. US Naval Hospital Okinawa PACOM Armed Services Blood Bank Center (ASBBC) is mandated by FDA to conduct pathogen reduction process for all collected blood platelets. Supplies of the platelet sets are historically sustained thru a drop shipment contract. The suggested vendor is the sole manufacturer and provider of the platelet sets.


Fenwal, Inc., is the only source capable of meeting the government’s minimum requirements.


Delivery Period: 1 October 2026 through 30 September 2027


Delivery Location: MAB, DLA TROOP SUPPORT XDOCK WEST PROJECT, C/O CARDINAL HEALTH MPS DISTRIBUTION CENTER, 4551 EAST PHILADELPHIA STREET, ONTARIO CA 91761


This notice of intent is not a request for competitive proposals, and no formal solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement. Submissions must include management, technical, and cost data in sufficient detail accompanied by convincing evidence to clearly demonstrate the capability to provide the required equipment and preventive maintenance. Capability statements shall not exceed four (4) pages (8.5" x 11" format) using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. Requests for documentation, inquiries for additional information, or submissions consisting solely of questions will not be considered affirmative responses. A determination by the Government not to compete this requirement based on responses to this notice is solely within the discretion of the Government. Information received will be considered exclusively for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole-source purchase order.


Response Instructions: If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to:


  • Mariangela Monsalve at mariangela.j.monsalve.civ@health.mil
  • Bobbie Dobberstein at bobbie.s.dobberstein.ctr@health.mil

The closing date for challenges is no later than 1000 Pacific Daylight Time, Friday, August 28, 2026.


NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

Similar Contracts

Same NAICS industry code

NAICS: 325413
New
Federal
BRAND NAME OR EQUAL Flow Cytometry Reagents for the MPLS VA
Solicitation # 36C26326R0072
Solicitation 36C26326R0072 is a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract issued by the Department of Veterans Affairs Network Contracting Office 23 for the procurement of brand name or equal flow cytometry reagents. The contract is designated as a sole-source award to Becton Dickinson (BD) under FAR 6.103-1 and 12.102(a), justified by the proprietary compatibility requirements of the reagents with VA-owned BD instruments, specifically the FACSCanto, FACSLyric, and FACS Lyse Wash Assistant. The scope of work supports clinical immunophenotyping for diagnostic and prognostic patient care at the Minneapolis VA Health Care System, located at One Veterans Drive, Minneapolis, MN 55417. The contract period runs from October 1, 2026, through September 30, 2031, consisting of a base period followed by four one-year ordering periods. Deliverables include a catalog of BD-branded reagents, such as various CD markers and antibodies, categorized by FDA regulatory designations including In Vitro Diagnostic (IVD), Analyte Specific Reagent (ASR), and Research Use Only/Good Manufacturing Practice (RUO/GMP). The procurement is managed by Contracting Officer Traci Johannes, with all performance and acceptance occurring at the Minneapolis VA facility. No set-asides were used for this action, and the primary NAICS code is 325413 for Pharmaceutical Preparation Manufacturing.
Network Contract Office 23 (36C263)

POSTED

about 23 hours ago

DEADLINE

in 10 days
View Details
NAICS: 325413
New
Federal
Procurement of commercial-off-the-shelf (COTS) proprietary BioFire diagnostic assay kits and refurbished systems
Solicitation # N6817126QN076
The Naval Supply Systems Command Fleet Logistics Center Sigonella intends to award a firm-fixed-price, sole-source purchase order to Bio Fire Defense, LLC for the procurement of proprietary BioFire diagnostic assay kits and four refurbished FilmArray 2.0 systems. This acquisition supports the Naval Medical Research Unit Europe, Africa, Central in its infectious disease surveillance and research operations across Europe, Africa, and the Middle East. The required materials include various specialized panels for global fever, blood culture identification, gastrointestinal, and respiratory diagnostics, all of which must be delivered to NAS II Sigonella, Italy, within 15 calendar days of the order. The sole-source justification is based on the proprietary nature of the consumables and a Foreign Ownership, Control, or Influence mitigation agreement, which mandates that U.S. Federal Government entities procure these specific biological defense assets exclusively through Bio Fire Defense, LLC. While this is a notice of intent for a sole-source award, interested parties may submit capability statements by August 31, 2026. To be considered, respondents must provide evidence of FOCI agreement compliance, the ability to provide exact part numbers without substitutions, cold-chain logistical capabilities for delivery to Italy, and confirmation of valid OEM warranty support.
Navsup Flc Sigonella Naples Office

POSTED

about 23 hours ago

DEADLINE

in 17 days
View Details

More opportunities from Department Of Defense → Defense Health Agency Hcd West

Same awarding agency

NAICS: 325120
New
Federal
Oxygen Generation System
Solicitation # HT941026Q2064
The Defense Health Agency Healthcare Contracting Division-West is soliciting quotes for a firm-fixed-price contract to provide a complete medical-grade oxygen generation system for the United States Naval Hospital Guam. The scope of work includes the procurement of a system utilizing PSA or VSA technology, featuring oil-free air compressors, dryers, filtration systems, oxygen receivers, and a 30-cylinder filling ramp. The contractor is responsible for all OCONUS freight logistics, customs clearances, and on-site installation at Building 50 in Agana Heights, Guam, with a final delivery deadline of January 30, 2027. The system must comply with NFPA 99, USP, and FDA regulations, and requires third-party verification prior to government acceptance. The contract structure includes a base period for equipment and installation, followed by four optional years of semi-annual preventive maintenance and repair services. A minimum one-year OEM warranty must be included in the base pricing, with maintenance options commencing upon the warranty's expiration. Award will be determined via a Delivery Requirement Price Tradeoff, where technical capability is a pass/fail gatekeeper requiring OEM authorization, and the government will trade off the supplier's risk score from the Supplier Performance Risk System (SPRS) against the quoted price. All invoicing and payment requests must be processed electronically through the Wide Area WorkFlow (WAWF) system.
Industrial Gas Manufacturing

POSTED

about 23 hours ago

DEADLINE

in 3 days
View Details
NAICS: 811210
New
Federal
Radiation Oncology’s Xstrahl superficial x-ray unit Services
Solicitation # HT941026Q2070
Solicitation HT941026Q2070 is a request for quotes for a firm-fixed-price, non-personal services contract to provide full service and maintenance for the Xstrahl superficial x-ray unit at the Naval Medical Center San Diego. This acquisition is 100 percent set aside for small businesses under NAICS code 811210. The contract structure consists of a base period from August 14, 2026, to August 13, 2027, with four subsequent one-year option periods extending through August 13, 2031. The scope of work includes unlimited telephone support, scheduled preventive maintenance, corrective maintenance, and emergency response coverage to ensure uninterrupted equipment operation. Award will be based on best value, where technical capability serves as a mandatory pass/fail gate. Once technical acceptability is established, the government will perform a trade-off analysis between past performance and price, with past performance explicitly weighted as more important than price. Qualified offerors must submit a technical capability statement of no more than three pages, past performance questionnaires for two recent and relevant contracts, and a completed quote sheet. All submissions must be sent as a single PDF file to the designated contracting point of contact by 12:00 PM Pacific on August 13, 2026. Contractor personnel are required to comply with DBIDS access control, execute non-disclosure agreements, and adhere to NIST SP 800-171 cybersecurity standards.
Electronic and Precision Equipment Repair and Maintenance

POSTED

about 23 hours ago

DEADLINE

in 7 days
View Details